Healthcare >> CEO Interviews >> December 18, 2000
JOHN DOBAK, MD, is the Founder/CEO of INNERCOOL Therapies, Inc.
INNERCOOL is an early stage company developing a novel therapeutic
catheter to treat neurovascular and cardiovascular disease. The company
has completed two rounds of venture financing with Kleiner, Perkins,
Caufield, and Byers, Institutional Venture Partners, and Technology
Partners totaling $13.4 million. Prior to starting INNERCOOL, Dr. Dobak
founded CryoGen, Inc., and was the inventor of the CryoGen cryosurgical
technology. CryoGen is a medical device company marketing a novel
cryosurgical tool for gynecology and cardiac arrhythmia surgery. Dr.
Dobak led the development of CryoGen from 1994-1998, raising $20 million
in equity and debt financing and government grants. Dr. Dobak remains on
the CryoGen Board of Directors and serves as the Chief Technology
Officer. Dr. Dobak is a recipient of the 1999 MIT's Technology Review
Top 100 innovators of the New Millennium Award, a recipient of the 1999
Russel B. Scott Most Innovative Research Award, and a recipient of the
1999 Medical Device Manufacturers Medical Design Excellence Award. He
was also the recipient of an SBIR grant in 1995. He has 12 issued
patents and over 15 publications in the medical literature. Dr. Dobak
received an MD from the University of California, San Diego, and a BS in
Biology from the University of California, Los Angeles. After graduating
from medical school, Dr. Dobak completed a post-doctoral fellowship in
Molecular Biology at the Scripps Research Institute. He subsequently
completed an internship in internal medicine at UCLA-Harbor County
Hospital. Dr. Dobak is licensed to practice medicine in the state of
California. Profile
Dr. Dobak: INNERCOOL Therapies is developing a vascular catheter that
induces and reverses hypothermia, or mild cooling, for
